Monthly: Fate Therapeutics (FATE: $2.37) shares post worst month in six months

Press/Media: Press / Media

PeriodNov 1 2024

Media coverage

1

Media coverage

  • TitleMonthly: Fate Therapeutics (FATE: $2.37) shares post worst month in six months
    Media name/outletGlobal Round Up - Bullish & Bearish Signals
    Country/TerritoryUnited States
    Date11/1/24
    PersonsMichael Lee
View all 1
View less